Hikma Pharmaceutical | HIK - Ebit

Stock Price
1,385.00
Daily Change
-17.50 -1.25%
Monthly
8.80%
Yearly
-27.07%
Q2 Forecast
1,361.73

Hikma Pharmaceutical reported $348M in EBIT for its fiscal semester ending in December of 2025.





Ebit Change Date
Almirall EUR 30.23M 12.8M Dec/2025
argenx SE USD 371.14M 21.17M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Autolus Therapeutics Ltd USD -72.47M 845K Dec/2025
Bayer EUR 1.11B 1.51B Dec/2025
Fresenius EUR 713M 139M Dec/2025
Galapagos EUR 780.56M 822.23M Dec/2025
Genmab DKK 260M 199M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Hikma Pharmaceutical USD 348M 31M Dec/2025
Lonza CHF 673M 54M Jun/2025
Merck EUR 474M 738M Dec/2025
Orion EUR 114.8M 213.3M Mar/2026
Recordati EUR 278.23M 112.58M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.94B 239M Mar/2026
UCB EUR 1.29B 571M Dec/2025